UK Markets open in 4 hrs 13 mins

Nomi Health Operates Monoclonal Antibody Treatment Center in Utah as Part of COVID-19 Community Care Delivery

·3-min read

With capacity to treat over 100 patients per day, this expands access to life-saving COVID-19 therapeutics vital to treating Americans without overburdening the healthcare system

OREM, Utah, December 02, 2021--(BUSINESS WIRE)--Nomi Health, the direct healthcare company rewiring how care is bought, paid for and delivered, today announced the operation of its first monoclonal antibody treatment center, first launched in Utah in November 2021. The center, located in Orem, supports the Utah Department of Health and furthers Nomi Health’s COVID-19 care solution set while providing care for those unable to access traditional healthcare settings.

The center, located at 1350 Sandhill Road, Orem UT, is open Monday - Saturday from 7a.m. - 7p.m. MT. Due to the wait period post treatment the last available appointment time is 5:30p.m. MT.

"Infectious disease experts nationally have established monoclonal antibody treatment as highly effective -- yet woefully underused -- in our defense against COVID-19. So when the State of Utah called upon Nomi Health to help expand access to care, we answered the call and donated the rebuild of one of our facilities for the purpose of providing a community access model for monoclonal treatment in Utah," said Mark Newman, CEO and co-founder of Nomi Health. "We applaud Utah for continuing to embrace this treatment, as more states do so. Not only is it life-changing for affected patients, it is critical to avoiding the complete overburden of our healthcare system as the rate of new COVID-19 cases grows at an alarming rate and as ICU beds continue to fill up."

Following a procurement process led by the Utah Department of Health, Nomi Health joins other providers to fast track the delivery of monoclonal antibody treatments for qualified Utahns. Those who test positive for COVID-19 at any Utah site will be contacted to determine if they are eligible for treatment, and then may visit any open treatment center listed here:

"We put rigorous protocols in place to ensure we maintain a safe and comfortable environment for patients," said Dr. June Steely, medical director, Nomi Health, who is overseeing the center. "This is a natural extension of the level of access and great patient experience Utahns receive from Nomi Health on testing and vaccination."

Among the nation’s leading direct healthcare companies coordinating COVID-19 testing and vaccination efforts at scale throughout the U.S., Nomi Health has served as a trusted partner in more than eight states nationwide since the early days of the pandemic, serving approximately 30,000 patients per day with effective, quality testing and vaccines, and now treatment.

About Nomi Health

Nomi Health is a direct healthcare company successfully re-wiring how healthcare is delivered and paid for in America, to the benefit of patients, providers and the buyers of healthcare in both the public and private sectors. Based in Orem, Utah, we’re a team of over 2,000 nationwide, each actively working to lower care costs, widen care access and improve the experience for all. The company’s Nomi Care platform -- featuring local clinical and operations field teams, a sustainable supply chain, and seven networked laboratories - have served over eight million Americans with everyday healthcare services, including powering up to five percent of the nation’s COVID-19 testing volumes. Nomi Connect is a business operating system and payment platform enabling organizations to purchase healthcare directly and providers to be paid in real time. Nomi Health cross-functional leadership team hails from America’s most established clinical, healthcare, technology and finance organizations. Visit us @NomiHealth and

View source version on


Media Contact
Jenny Olson
mPR, Inc. for Nomi Health

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting